Duke Cancer Center

One of the greatest advantages of performing preclinical research through the Duke’s PTRU is the wealth of resources available to our team through our collaborations with the wider Duke University Health system. The PTRU is supported by designated institutional cores and shared resources that offer a wide variety of cutting edge services. In the Times Higher Education World University Rankings’, Duke University ranked 6th in the nation for clinical, preclinical, and health science research. Additionally, the Duke University School of Medicine ranked 8th in research and 8th in primary care among all medical schools in the nation, according to new U.S. News & World Report rankings.

The unique advantage of the partnering with Duke’s Preclinical Translational Research Unit is the seamless nature with which we integrate the full range Duke’s resources into our services. The PTRU provides a single unified point of contact for our partners.